Nu-Med Plus (NUMD) EPS (Diluted) Growth (5y) (2020 - 2025)
Nu-Med Plus (NUMD) EPS (Diluted) Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 56.15% |
| Sep 30, 2025 | 57.19% |
| Jun 30, 2025 | 62.93% |
| Mar 31, 2025 | 41.10% |
| Dec 31, 2024 | 52.55% |
| Sep 30, 2024 | 42.34% |
| Jun 30, 2024 | 48.63% |
| Mar 31, 2024 | 52.00% |
| Dec 31, 2023 | 37.92% |
| Sep 30, 2023 | 56.70% |
| Jun 30, 2023 | 41.42% |
| Mar 31, 2023 | 37.59% |
| Dec 31, 2022 | 18.14% |
| Sep 30, 2022 | 27.16% |
| Jun 30, 2022 | 25.13% |
| Mar 31, 2022 | 2.96% |
| Dec 31, 2021 | -49.26% |
| Sep 30, 2021 | 39.33% |
| Jun 30, 2021 | 8.33% |
| Mar 31, 2021 | -48.06% |